Solid Oral Dosage Solutions | Coatings, Excipients & Packaging

Innovation & Expertise Matter in Solid Oral Dose Development

With the growth of diabetes treatment and GLP-1 therapies driving the conversation around injectable reformulation to solid oral dose, picking the right partner can make all the difference. From excipient selection to shelf-stable formulation design, let Colorcon troubleshoot and help you overcome every development challenge you may face, keeping patient experience and therapeutic performance at the forefront.

What We Can Learn from the GLP-1 Industry

While injectable GLP-1 therapies have transformed diabetes treatment, the rise of oral formats highlights a broader opportunity: creating medicines that are easier to take, distribute, and integrate into everyday life.

From Injectable to Solid Oral Dose: What It Takes to Make the Switch

Developing an oral dosage form takes more than simply turning an injectable into a tablet or capsule. To do it well, you need the right formulation strategy, balancing manufacturability, stability, protection and patient experience.